Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Cohen Yuval, Chief Executive Officer. Director active across 1 company, notably Corbus Pharmaceuticals Holdings, Inc.. Aggregated, 12 reports have been logged. Split: 3 buys · 3 sells. Total volume traded: €306k. History available since 9 March 2022. The latest transaction was disclosed on 7 August 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Cohen Yuval
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8,600 shares@ US$0.370.6% of flowCommon StockSEC:0001209191-22-017449:0
Canonical exit: 7 Jun 2022 (T+90)
12 of 12 declarations
About Cohen Yuval
Cohen Yuval is Directeur Général and Chief Executive Officer at Corbus Pharmaceuticals Holdings, Inc. His 11 reported filings, all included in the available sample, cover the period from 2022-03-09 to 2026-02-18. In these recent filings, the total buy amount is EUR 6408 and the total sell amount is EUR 150666, and the most frequent transaction nature is Attribution.